November 29th Networking Event for all NMD4C Members
The NMD4C are excited to extend an invitation to our members to join us at a Networking Event on November 29th at 2:10pm ET. This event is open to all NMD4C members and is an opportunity to meet and network with fellow colleagues, early-career clinicians and researchers, NMD4C investigators and working group members, and to discuss all things neuromuscular!
In recent times, the sweeping migration of meetings and conferences to online platforms has resulted in fewer opportunities for informal networking and interaction that would normally be far more accessible at the variety of meetings and conferences which are hosted during a regular, in-person calendar year. To address this gap, the NMD4C, with input from our early-career community, has made the decision to host a networking event in Gathertown – a platform that offers attendees the flexibility to join discussions within a group, and in private one-on-one meeting spaces. The NMD4C strives to provide opportunities for our early-career members to meet and network with each other, and to create spaces for open discussion between early-career clinicians and researchers and prominent investigators from a variety of areas within the neuromuscular landscape; these informal discussions are an invaluable resource where collaborations are born, ideas nurtured and future research directions discovered.
The event will take place on Monday, November 29th from 2:10 – 3:00pm ET, during the network’s Annual Investigator Meeting. While the Investigator Meeting is open only to the network investigators and working group members, the networking event is open to all members, and offers the opportunity to network with the NMD4C’s steering committee, investigators, leaders and contributors who will be in attendance.
Register Here!
If you are interested in attending the event, please register at the following link: https://bit.ly/NMD4Cnetworkevent.
If you have any questions about the event, please contact NMD4C communications coordinator James Davis at .
Read next...
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.
New Best Practice Recommendations for SBMA Care in Canada
Congratulations to Dr. Kerri Schellenberg, the team of Canadian experts, NMD4C Steering Committee members and Investigators, on publishing the first Canadian SBMA care guidelines!
Advancing Neuromuscular Research and Care: Highlights from the 2025 NMD4C Annual Meeting
On September 11, NMD4C hosted its 2025 Annual Meeting in Ottawa, bringing together clinicians, researchers, trainees, and partners for a full day of collaboration, strategic dialogue, and community-building.
NMD4C Hosts Inaugural Clinical Summer School to Empower Canada’s Future Neuromuscular Leaders
On September 10–11, NMD4C hosted its inaugural Clinical Summer School in Ottawa, bringing together 19 neuromuscular clinical fellows from across Canada for two days of hands-on training, mentorship, and networking. Led by national experts and co-chaired by Drs. Gordon Jewitt and Marianne Nury, the program complemented NMD4C’s accredited lecture series and fostered peer connection through dedicated community-building sessions.
2026 Neuromuscular Postdoctoral Research Fellowships Funding Competition is Now Open!
Apply Or Share this opportunity with the trainees in your network — Deadline: October 14, 2025. Hosted by Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC)
Announcing the 2026 Neuromuscular Clinical Fellowship Award Recipients
We are excited to share that the 2026 Neuromuscular Clinical Fellowship Awards have been awarded! These fellowships strengthen clinical training in neuromuscular medicine and help prepare the next generation of specialists who will advance neuromuscular care across Canada.